李亞欣Hsin-Li Ya陳緯靜WEI-CHING CHEN醫療產業科技管理學系2026-10-059999-12-312021https://handle.ncl.edu.tw/11296/69r2yuhttps://scholars.csmu.edu.tw/handle/123456789/20345目的:隨著進入「人口負成長時代」,老年人口占比超過20%的超高齡社會也將提前一年於2025年到來(楊璨伊,2020)。快速增加的老年人口,也將快速增加老化相關疾病患者,其中帕金森氏症(Parkinson’s disease)為一種好發於老年人口的神經退慢性疾病,而此疾病對於患者、家屬及社會都會造成許多醫療經濟成本負擔。因此本研究希望透過統計資料了解帕金森氏症患者在跨區的醫療利用狀況,探討其患者在不同個人背景、健康狀態及醫療因素下,其醫療利用、存活天數與平均每生存日的醫療費用之差異。方法:本研究資料來源為衛生福利部衛生福利資料科學中心之健保資料庫百萬人抽樣檔,以2006年的帕金森氏症新病例為研究對象(ICD-9-CM診斷碼為332.0),刪除前一年已確診的患者並且追蹤至2011年。本研究使用統計軟體SAS 9.4 進行資料處理,進行描述性統計以及推論性統計,應用二元邏輯斯迴歸分析了解影響帕金森氏症患者各個變項與患者是否跨區之相關因素,進一步使用Cox對比涉險模式進行存活分析並且計算風險率,用以探討帕金森氏症患者的存活相關因素。結果:本研究樣本共1,215名個案,從2006年追蹤至2011年的結果中,以女性患者(50.62%)居多,年齡多分布於71-80歲(41.65%)之間,投保金額主要為1-28,000元(61.07%),患者多為居住於中度都市化市鎮(27.00%),多數患者前往地區醫院與基層院所(43.62%)就醫,到研究追蹤時間為止,以沒有確診死亡(62.14%)的患者為多數,最後沒有跨區的患者(61.98%)佔多數。在卡方分配中,居住地都市化程度及主要就醫機構層級與是否跨區有顯著相關。是否跨區中以邏輯斯迴歸進行分析,居住地都市化程度有達統計上的顯著水準(p=0.001);在主要就醫機構層級中,區域醫院相較於醫學中心有2.609倍之跨區風險,有達統計上的顯著水準(95%C.I.:1.909-3.566, p=<0.0001),地區醫院與基層院所相較於醫學中心有2.992倍之跨區風險,有達統計上的顯著水準(95%C.I.:2.238-4.001, p=<0.0001)。Cox對比涉險模式存活分析結果方面,性別以男性患者為參考組,女性患者相較於男性患者有0.837倍之死亡風險,有達統計上的顯著差異(95%C.I.:0.747-0.937,p=0.002);在年齡分組方面,以60歲以下患者為參考組,61-70歲的患者相較於60歲以下的患者有1.162倍之死亡風險,71-80歲的患者相較於60歲以下的患者有1.402倍之死亡風險,有達統計上的顯著差異(95%C.I.:1.194-1.646,p=<0.0001),81歲以上的患者相較於60歲以下的患者有1.929倍之死亡風險有達統計上的顯著差異(95%C.I.:1.615-2.304,p=<0.0001)。結論:從本研究結果可知,女性患者比男性患者存活天數多,其平均每生存日的醫療費用也較男性高;年齡越大其存活天數越低死亡風險越高;投保金額較高者醫療次數、費用及存活天數平均明顯較多,其死亡風險也較低;都市地區的醫療次數、醫療費用及存活天數都較偏遠鄉鎮高,且死亡風險較偏遠鄉鎮低;前往醫學中心的患者其醫療費用及存活天數都較高;確診死亡的患者其成本效益高於沒有確診死亡的患者,有跨區的患者平均醫療費用及平均每生存日的醫療費用高於沒跨區患者。Purpose:With the entry into the "era of negative population growth", a super-aged society in which the elderly account for more than 20% of the population will arrive one year earlier in 2025 (Yang Canyi, 2020). The rapidly increasing elderly population will also rapidly increase the number of patients with aging-related diseases, among which Parkinson's disease is a neurodegenerative chronic disease that occurs in the elderly population. economic cost burden. Therefore, this study hopes to understand the cross-regional medical utilization of Parkinson's disease patients through statistical data, and to explore their medical utilization, survival days and average medical expenses per survival day under different personal backgrounds, health status and medical factors. difference.Method:The data source of this study is the health insurance database of the Ministry of Health and Welfare Health and Welfare Data Science Center, which is a sample file of millions of people. The new cases of Parkinson's disease in 2006 were used as the research object (ICD-9-CM diagnostic code was 332.0). Before deletion One year of patients diagnosed and tracked to 2011. In this study, the statistical software SAS 9.4 was used for data processing, descriptive statistics and inferential statistics, and binary logistic regression analysis was used to understand the factors that affect the variables of Parkinson's disease patients and whether the patients were cross-regional, and further used Cox to compare Survival analysis was performed using risk-involved patterns and hazard ratios were calculated to explore factors associated with survival in patients with Parkinson's disease.Result:There are a total of 1,215 cases in the sample of this study. The results tracked from 2006 to 2011 were mostly female patients (50.62%), most of whom were aged 71-80 (41.65%), and the insured amount was mainly 1-28,000 Yuan (61.07%), most of the patients lived in moderately urbanized cities and towns (27.00%), and most of the patients went to regional hospitals and grassroots institutions (43.62%) for medical treatment. As of the study tracking time, there were no confirmed deaths (62.14%). ) was the majority, and finally the patients without cross-regional (61.98%) were the majority. In the chi-square distribution, the degree of urbanization of the place of residence and the level of the main medical institutions are significantly related to whether it is cross-regional. Logistic regression is used to analyze whether there is a cross-regional area, and the degree of urbanization of the residential area has reached a statistically significant level (p=0.001); in the level of major medical institutions, regional hospitals have 2.609 times the cross-regional risk compared with medical centers. , reaching a statistically significant level (95%CI: 1.909-3.566, p=<0.0001), regional hospitals and primary institutions have 2.992 times the cross-regional risk compared with medical centers, reaching a statistically significant level ( 95%CI: 2.238-4.001, p=<0.0001). In terms of the survival analysis results of Cox's comparative risk-related model, male patients were used as the reference group for gender, and female patients had 0.837 times the risk of death compared with male patients, which was statistically significant (95%CI: 0.747-0.937, p= 0.002); in terms of age grouping, taking patients under the age of 60 as the reference group, patients aged 61-70 had 1.162 times the risk of death compared with patients under the age of 60, and patients aged 71-80 were compared with those under the age of 60. of patients had a 1.402-fold higher risk of death, a statistically significant difference (95% CI: 1.194-1.646, p=<0.0001), and patients over 81 years of age had a 1.929-fold higher risk of death compared to patients under 60 years of age There was a statistically significant difference (95% CI: 1.615-2.304, p=<0.0001).Conclusion:From the results of this study, it can be seen that female patients have more survival days than male patients, and their average medical expenses per survival day are also higher than that of male patients; the older the age, the lower the survival days, the higher the risk of death; the higher the insurance amount, the number of medical treatments and expenses The average number of days and survival days is significantly more, and the risk of death is also lower; the number of medical treatments, medical expenses and survival days in urban areas are higher than those in remote towns and towns, and the risk of death is lower than that in remote towns; The number of days is higher; the cost-effectiveness of patients with confirmed death is higher than that of patients without confirmed death, and the average medical expenses and average medical expenses per living day of patients with cross-regional disease are higher than those of patients without cross-regional disease.帕金森氏症跨區醫療醫療資源使用存活天數Parkinson's DiseaseCross-regional medical careUse of medical resourcesSurvival days帕金森氏症之跨區醫療資源使用狀況thesis